Wenger Vieli advised Serpentine Ventures on the deal. The Swiss Startup Group obtained a FINMA licence for collective assets for its subsidiary Serpentine Ventures. Serpentine Ventures is Switzerland’s...
You must be a Standard 1 Year member to access this content.
Wenger Vieli advised advised numarics. numarics, a Zurich based Start-up that offers an all-in-one-solution for SMEs from accounting to tax optimisation powered by specialised financial experts...
You must be a Standard 1 Year member to access this content.
Wenger Vieli advised MAIT on the deal. MAIT, headquartered in St. Gallen, reached agreement on the acquisition of Swiss-based Cytrus – a subsidiary of bytics Group and...
You must be a Standard 1 Year member to access this content.
Wenger Vieli advised Inyova on the deal. Inyova launched a Crowdinvesting campaign. Inyova is the leading impact investing platform in Europe and managed approximately CHF 173 million...
You must be a Standard 1 Year member to access this content.
Wenger Vieli advised Inyova on the deal. Inyova launched a Crowdinvesting campaign. Inyova is the leading impact investing platform in Europe and managed approximately CHF 173 million...
You must be a Standard 1 Year member to access this content.
Wenger Vieli advised Five T on the deal. F10, the leading innovation ecosystem for FinTech and InsurTech, announced the closing of a new funding round in...
You must be a Standard 1 Year member to access this content.
Wenger Vieli advised Five T on the deal. F10, the leading innovation ecosystem for FinTech and InsurTech, announced the closing of a new funding round in...
You must be a Standard 1 Year member to access this content.
Wenger Vieli advised NLS Pharmaceutics on the deal. NLS Pharmaceutics Ltd, a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients...
You must be a Standard 1 Year member to access this content.
Wenger Vieli advised NLS Pharmaceutics on the deal. NLS Pharmaceutics Ltd, a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients...
You must be a Standard 1 Year member to access this content.
CMS advised Bruker on the deal. Wenger Vieli advised Tofwerk. Bruker Corporation, a NASDAQ-listed US tech company in the analytical instrumentation sector, has acquired a stake...
You must be a Standard 1 Year member to access this content.
Wenger Vieli advised the shareholders of 1plusX on the deal, with Advestra. Pestalozzi advised TripleLift. 1plusX, a Swiss-based start-up and global marketing technology company, has announced...
You must be a Standard 1 Year member to access this content.
Borel & Barbey advised Artmyn on this acquisition. Wenger Vieli advised Invaluable, in collaboration with Goodwin Boston. Invaluable, the world’s leading online marketplace for premier auction...
You must be a Standard 1 Year member to access this content.
